🏛️ Hemp Deadlines, Tax Reality, And A Court Watching Closely

Built by a former cannabis regulator, Policy, Decoded helps operators read the policy terrain before it shifts beneath their feet.

Today’s edition tracks three pressure points shaping the market right now: a Supreme Court case probing federal cannabis logic, states racing to install guardrails before hemp policy resets this fall, and governments confronting the hard ceiling on cannabis tax expectations.

Today’s edition is supported by Forward Future AI and The Deep View. To sponsor Policy, Decoded and reach the executives, investors, and policymakers who read this briefing, reply to this email and we will send details.

🥤 Hemp’s policy countdown
💰 Cannabis tax reality check
⚖️ Federal law under scrutiny

⚖️ Supreme Court Tests The Marijuana Gun Ban In A Patchwork Nation

The Supreme Court is signaling discomfort with a federal rule that treats marijuana use as a categorical marker of firearm risk, especially when the line between casual use and disqualifying status stays blurry. Justice Amy Coney Barrett pressed on whether illegality under the Controlled Substances Act is a workable stand-in for a real judgment about dangerousness. Several justices also circled the enforcement reality: prosecutors and agents effectively decide who qualifies as an unlawful user while state legality varies sharply. The government leaned on Congress’s authority to disarm groups it views as risky, even when the proxy is broad. A narrower ruling would not harmonize federal and state law, yet it would reshape enforcement posture and litigation strategy across legalization states. (Reuters)

🥤 Hemp THC Hits A Deadline As Prosecutors Step Onto The Field

States are racing to build age limits, testing standards, and retail rules while Congress threatens to redraw the definition of lawful hemp THC on November 12th. Pennsylvania’s discussion includes routing THC drinks through familiar alcohol-style compliance channels, while South Carolina is moving toward a 21-and-up framework with tighter labeling and oversight. Against that backdrop, federal charges against a Kansas hemp THC operator land as a warning shot for businesses running on aggressive interpretations of the Farm Bill. Charging decisions turn on measurement, formulation, and distribution facts that feel technical until they become criminal. Near term, expect a chilled supply chain and a sharper premium on conservative compliance, especially for interstate sellers. (BucksCo.Today)

🏥 Medicare’s CBD Pilot Turns Cannabinoids Into A Standards Fight

CMS is moving toward a Medicare pilot that would cover CBD therapies, placing cannabinoid products inside the country’s strictest reimbursement and audit culture. CMS Administrator Mehmet Oz has described the pilot as imminent, with April as the anticipated rollout window. Congress already put guardrails in play through an appropriations cap tied to a per-container THC threshold with a phase-in period, keeping hemp politics welded to health policy. Once coverage is on the table, quality, dosing, and claims controls stop being messaging debates and start deciding who gets paid. The next pressure point is whether the pilot’s eligibility rules reward disciplined, measurable products or invite loopholes that collapse credibility on day one. (Washington Post)

🏛️ Michigan Tests Whether A New Wholesale Tax Can Survive The Math

A bill from state Sen. Jonathan Lindsey would repeal Michigan’s new 24% marijuana wholesale tax that took effect January 1st. The Michigan Cannabis Industry Association is already appealing a Court of Claims decision that declined to block the tax, arguing the levy conflicts with the 2018 voter initiative framework. Bipartisan sponsorship signals lawmakers are hearing stress from inside the regulated market, not just from ideologues. Wholesale layer taxes land hardest in a price-collapsed market, where every point gets passed, absorbed, or dodged. If the tax stays, expect more litigation and more margin pressure where compliance spending gets cut first. (Cannabis Equipment News)

💰 Los Angeles Confronts The Ceiling On Cannabis Tax Collection

Los Angeles says cannabis businesses owe roughly $400 million in unpaid city taxes, and staff expect to recover only a small share through current enforcement. That gap reflects structural reality: governments budget against theoretical revenue while the legal market fights price compression, illicit competition, and thin margins. Shuttered operators, bankruptcies, and asset transfers turn tax bills into paperwork rather than money. City leaders are weighing tougher collection tools, and those tools can recover dollars while also accelerating exits among fragile licensees. The fiscal lesson for other cities is blunt: stable revenue follows stable markets, and tax policy can break that stability. (Los Angeles Times)

🔒 Oklahoma’s Bond Blowup Puts Courtroom Discipline Under A Microscope

Oklahoma Attorney General Gentner Drummond is criticizing a $100,000 bond for Hao Chen, whom prosecutors describe as tied to a sprawling licensing fraud scheme connected to roughly $1.5 billion in black market marijuana. The credibility test sits in follow-through: coverage indicates Chen’s attorney said the attorney general’s office did not appear at the bond hearing, leaving the court without the state’s live argument. Oklahoma’s post-crackdown posture has been about restoring order after a chaotic licensing boom, and marquee cases are supposed to demonstrate the system can execute. When the process looks loose, defendants gain leverage and deterrence weakens. The next inflection point is whether the state tightens courtroom performance as fast as it tightens its press statements. (OKC FOX 25, Yahoo News)

⚖️ Connecticut Licensing Faces Another Dormant Commerce Clause Test

Connecticut resident Brant Smith is urging a federal judge to keep alive his challenge to the state’s cannabis licensing program under the dormant Commerce Clause. Smith is attacking the parts of the scheme that he says privilege in-state participation and shut out would-be entrants who cannot satisfy residency-linked conditions. The state’s best defense remains familiar: cannabis is federally illegal, so courts should not use interstate commerce doctrine to police a market Congress still bans. The risk for states is that courts keep splitting on that logic, and every split invites another plaintiff to take a swing at residency and preference structures. Program designers may need to pursue social equity and local participation with tools that look neutral on paper, because this litigation pressure is durable. (Law360)

🌽 Nebraska Medical Cannabis Has Money Now, Yet Federal Cover Is Missing

Nebraska lawmakers advanced LB 1235 to give the Nebraska Medical Cannabis Commission operating authority after a basic failure: no money and no way to raise any. The bill pays commissioners $12,500, authorizes licensing fees up to $50,000, creates a cash fund, and allows fingerprinting for license applicants, and it passed 40-0 on first-round approval. In the same week, Nebraska was excluded from the congressional spending provision that blocks the Justice Department from using federal dollars to interfere with state medical marijuana programs, even though that list covers 47 states. Sen. Pete Ricketts said he is not on Senate Appropriations and did not know why Nebraska was left off, reinforcing the message that the federal posture remains unsettled for a new program. Nebraska can finally build administrative plumbing, yet providers and investors will still price in higher perceived federal risk until appropriators fix the list. (Omaha World Herald, Nebraska Examiner)

🗳️ Virginia Campaign Turns A Hearing Clip Into A Cannabis Wedge

Virginia state Sen. Ghazala Hashmi says she is unfazed after appearing in a political ad funded by Smart Approaches to Marijuana that criticizes legalization. The ad pulls footage from a legislative hearing where Hashmi raised concerns about youth access during debate over retail cannabis policy. Hashmi says the clip strips away context and does not reflect her support for legalizing and regulating sales. The episode lands in the middle of a competitive Democratic primary where campaigns are looking for issues that travel well in short ads. Cannabis policy still fits that bill, which means lawmakers learn the same lesson every cycle: anything said in a hearing room can end up in a campaign spot. (WVTF)

🏥 Adult Accidental THC Ingestion Keeps Landing In Emergency Rooms

A scoping review from Emory clinicians found adult unintentional ingestion cases frequently tied to THC baked goods and candy, with dizziness, vomiting, tachycardia, and somnolence recurring across reports. Several cases presented with confusion, gait issues, weakness, and speech problems that initially looked like stroke, burning time and imaging on a preventable packaging and serving-clarity problem. Older patients appeared to fare worse, often after consuming multiple servings without realizing it. Many patients returned to baseline within 24 hours, yet admissions were common and those costs land on families, hospitals, and payers. If cannabinoids are going to live in normal retail channels, serving clarity has to be enforceable and boring. (ScienceDirect, Society of Hospital Medicine Abstracts)

💊 Germany Keeps Buying And Canada Keeps Supplying

Germany’s medical cannabis import volumes remain massive, and Canada continues to supply the largest share, reflecting export scale and GMP discipline. Portugal has emerged as a major second source, with other European suppliers trailing, and domestic cultivation remains limited relative to demand. Canadian influence is also deepening through distribution and platform stakes, which matters because control of fulfillment can be as strategic as control of production. For executives, Europe rewards documentation, repeatability, and logistics discipline more than brand mythology. Germany is functioning as a central gate for global medical supply chains, shaping who invests and where capacity goes next. (StratCann)

🏪 Native Roots Sale Shows The Real Shape Of Colorado Consolidation

Verdant Capital Partners has a definitive deal to acquire the retail operations of Native Roots, a 17-store Colorado platform with long operating history. The transaction arrives after years of litigation among key insiders, which remains a common consolidation pathway in mature markets. Verdant is betting brand recognition and retail gravity still matter even when governance has scars. Regulators face the practical challenge of keeping approvals aligned with the pace of deals, because terms are usually settled long before the paperwork finishes. More stores under fewer capital stacks raises the stakes on compliance performance and labor stability as the differentiators that survive price compression. (Cannabis Equipment News)